 Source: JHVEPhoto Shutterstock.com Amylyx Pharmaceuticals NASDAQ: AMLX stock is rocketing higher on Thursday following an update from the FDA on its ALS treatment. A letter from the FDA reveals that it now supports AMX0035 for the treatment of ALS. 